Impacto da atenção farmacêutica na qualidade de vida e no perfil clínico de pacientes com hipertensão arterial assistidos pela estratégia saúde de família

Saved in:
Bibliographic Details
Main Author: Aquino, Aline Teixeira de
Publication Date: 2013
Format: Master thesis
Language: por
Source: Repositório Institucional da UFG
Download full: http://repositorio.bc.ufg.br/tede/handle/tede/9212
Summary: Introduction: Pharmaceutical care is a practice model that allows direct interaction between the pharmacist and the patient and the healthcare team. This practice uses the pharmacotherapeutic follow-up as a tool in the identification and resolution of Drug Related Problems, which can contribute to rational drug use and collaborate with achieving positive clinical outcomes that minimize the physical and psychosocial impact that chronic diseases and their treatment can promote the quality of life of patients. Objective: The aim of this study was to evaluate the impact of pharmaceutical care on quality of life and on clinical profile of patients with hypertension, assisted by the Family Health Strategy. Methods: Was conducted a longitudinal intervention study involving 29 patients with hypertension who were assisted by the Family Health Strategy of two Basic Health Units at the sanitary district north in the city of Goiânia - GO. They received pharmacotherapeutic follow-up for 12 months, through systematized, pre-schedule and documented home visits. Were included patients that had at least two of the following inclusion criteria: blood pressure greater than or equal to 140x90 mm ​​Hg, using three or more drugs, change in the therapeutic regimen two or more times in the last year , presence of co-morbidities, and history of non-adherence to antihypertensive therapy. Data collection was performed using follow-up pharmacotherapeutic reports, visits reports and form registration of clinical and laboratory parameters, “Mini Cuestionario de Calidad de Vida en Hipertensión Arterial” (Minichal) and Morisky-Green-Levine Questionnaire. The variables studied were the socio economic and demographic profile, clinical profile, lifestyle, Drug Related Problems, adherence to antihypertensive therapy and quality of life. For descriptive statistics were used mean, standard deviation and measures of absolute and relative frequency. For statistical tests were used the McNemar parametric test, odds ratio, and linear mixed models, generalized mixed models, linear mixed models. The threshold for statistical significance set at p <0.05, with a confidence interval of 95%.Results: The results showed that there was a reduction in the number of drug-related problem of security, increased self-reported adherence to antihypertensive treatment. There was improvement in quality of life related to the somatic manifestations domain and its correlation with the reduction in the number of drug-related problem of security. There was a significant reduction in abdominal circumference of female patients, there were found correlation between the quality of life for the somatic manifestations domain and the clinical outcomes of diastolic blood pressure, triglycerides and abdominal circumference. Just the diastolic blood pressure showed correlated with mental state domain of quality of life. There was a positive correlation between interventions directed to the patient related with the medications domain and the changes in the clinical results for fasting glucose. The life style domain presented correlation with systolic and diastolic blood pressure. Conclusions: The results showed that the pharmaceutical care reduced the number of security Drug Related Problems, improved quality of life related to the somatic manifestations domain. There was an increase in adherence to antihypertensive treatment declared by patients; however this did not influence the improvement of quality of life. Furthermore, the results revealed that there was a significant reduction in the women's measures abdominal circumference; that the pharmaceutical interventions directed to the patient influenced in the clinical results of fasting glucose, systolic and diastolic blood pressure; and that the changes observed in the clinical outcomes of diastolic blood pressure, triglycerides and abdominal circumference impacted on the quality of life related to the somatic manifestations.
_version_ 1871426357714485248
author Aquino, Aline Teixeira de
author_browse Aquino, Aline Teixeira de
author_facet Aquino, Aline Teixeira de
author_role author
bitstream.checksum.fl_str_mv 1b5845121203b85190fdc0482b0c2a3d
bd3efa91386c1718a7f26a329fdcb468
4afdbb8c545fd630ea7db775da747b2f
d41d8cd98f00b204e9800998ecf8427e
d41d8cd98f00b204e9800998ecf8427e
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
bitstream.url.fl_str_mv http://repositorio.bc.ufg.br/tede/bitstreams/3c41d5a9-18db-4f0e-a206-97eb972d61c1/download
http://repositorio.bc.ufg.br/tede/bitstreams/5d456919-a06e-4117-8468-1af213a0e161/download
http://repositorio.bc.ufg.br/tede/bitstreams/10fb2aae-e6aa-436e-9373-4f87809c047c/download
http://repositorio.bc.ufg.br/tede/bitstreams/bf4cca6b-1bc3-43de-89db-fc7c7b431bcf/download
http://repositorio.bc.ufg.br/tede/bitstreams/71f64e2b-b730-4576-9e46-ef3422651e5d/download
collection Repositório Institucional da UFG
contributor_str_mv Amaral, Rita Goreti
Lima, Dione Marçal
Amaral, Rita Goreti
Garrote, Clévia Ferreira Duarte
Zampieri , Ana Lúcia Teixeira de Carvalho
dc.contributor.advisor-co1.fl_str_mv Lima, Dione Marçal
dc.contributor.advisor-co1Lattes.fl_str_mv http://lattes.cnpq.br/4310011929664114
dc.contributor.advisor1.fl_str_mv Amaral, Rita Goreti
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/3665611660713029
dc.contributor.author.fl_str_mv Aquino, Aline Teixeira de
dc.contributor.authorLattes.fl_str_mv http://lattes.cnpq.br/7587958099382633
dc.contributor.referee1.fl_str_mv Amaral, Rita Goreti
dc.contributor.referee2.fl_str_mv Garrote, Clévia Ferreira Duarte
dc.contributor.referee3.fl_str_mv Zampieri , Ana Lúcia Teixeira de Carvalho
dc.date.accessioned.fl_str_mv 2019-01-09T13:08:46Z
dc.date.issued.fl_str_mv 2013-10-11
dc.format.none.fl_str_mv application/pdf
dc.identifier.citation.fl_str_mv AQUINO, Aline Teixeira de. Impacto da atenção farmacêutica na qualidade de vida e no perfil clínico de pacientes com hipertensão arterial assistidos pela estratégia saúde de família. 2013. 94 f. Dissertação (Mestrado Ciências da Saúde) - Universidade Federal de Goiás, Goiânia, 2013.
dc.identifier.uri.fl_str_mv http://repositorio.bc.ufg.br/tede/handle/tede/9212
dc.language.iso.fl_str_mv por
dc.publisher.country.fl_str_mv Brasil
dc.publisher.department.fl_str_mv Faculdade de Medicina - FM (RG)
dc.publisher.initials.fl_str_mv UFG
dc.publisher.none.fl_str_mv Universidade Federal de Goiás
dc.publisher.program.fl_str_mv Programa de Pós-graduação em Ciências da Saúde (FM)
dc.relation.cnpq.fl_str_mv 7337577453819502453
dc.relation.confidence.fl_str_mv 600
600
600
600
dc.relation.department.fl_str_mv 1545772475950486338
dc.relation.program.fl_str_mv -1006864312617745310
dc.relation.sponsorship.fl_str_mv -961409807440757778
dc.rights.driver.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFG
instname:Universidade Federal de Goiás (UFG)
instacron:UFG
dc.subject.cnpq.fl_str_mv MEDICINA::ANATOMIA PATOLOGICA E PATOLOGIA CLINICA
dc.subject.eng.fl_str_mv Pharmaceutical care
Hypertension
Medication adherence
Quality of life
dc.subject.por.fl_str_mv Atenção farmacêutica
Hipertensão arterial
Adesão à medicação
Qualidade de vida
dc.title.alternative.eng.fl_str_mv Impact of pharmaceutical care on the quality of life and clinical profile of patients with arterial hypertension assisted by the family health strategy
dc.title.eng.fl_str_mv Impacto da atenção farmacêutica na qualidade de vida e no perfil clínico de pacientes com hipertensão arterial assistidos pela estratégia saúde de família
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
description Introduction: Pharmaceutical care is a practice model that allows direct interaction between the pharmacist and the patient and the healthcare team. This practice uses the pharmacotherapeutic follow-up as a tool in the identification and resolution of Drug Related Problems, which can contribute to rational drug use and collaborate with achieving positive clinical outcomes that minimize the physical and psychosocial impact that chronic diseases and their treatment can promote the quality of life of patients. Objective: The aim of this study was to evaluate the impact of pharmaceutical care on quality of life and on clinical profile of patients with hypertension, assisted by the Family Health Strategy. Methods: Was conducted a longitudinal intervention study involving 29 patients with hypertension who were assisted by the Family Health Strategy of two Basic Health Units at the sanitary district north in the city of Goiânia - GO. They received pharmacotherapeutic follow-up for 12 months, through systematized, pre-schedule and documented home visits. Were included patients that had at least two of the following inclusion criteria: blood pressure greater than or equal to 140x90 mm ​​Hg, using three or more drugs, change in the therapeutic regimen two or more times in the last year , presence of co-morbidities, and history of non-adherence to antihypertensive therapy. Data collection was performed using follow-up pharmacotherapeutic reports, visits reports and form registration of clinical and laboratory parameters, “Mini Cuestionario de Calidad de Vida en Hipertensión Arterial” (Minichal) and Morisky-Green-Levine Questionnaire. The variables studied were the socio economic and demographic profile, clinical profile, lifestyle, Drug Related Problems, adherence to antihypertensive therapy and quality of life. For descriptive statistics were used mean, standard deviation and measures of absolute and relative frequency. For statistical tests were used the McNemar parametric test, odds ratio, and linear mixed models, generalized mixed models, linear mixed models. The threshold for statistical significance set at p <0.05, with a confidence interval of 95%.Results: The results showed that there was a reduction in the number of drug-related problem of security, increased self-reported adherence to antihypertensive treatment. There was improvement in quality of life related to the somatic manifestations domain and its correlation with the reduction in the number of drug-related problem of security. There was a significant reduction in abdominal circumference of female patients, there were found correlation between the quality of life for the somatic manifestations domain and the clinical outcomes of diastolic blood pressure, triglycerides and abdominal circumference. Just the diastolic blood pressure showed correlated with mental state domain of quality of life. There was a positive correlation between interventions directed to the patient related with the medications domain and the changes in the clinical results for fasting glucose. The life style domain presented correlation with systolic and diastolic blood pressure. Conclusions: The results showed that the pharmaceutical care reduced the number of security Drug Related Problems, improved quality of life related to the somatic manifestations domain. There was an increase in adherence to antihypertensive treatment declared by patients; however this did not influence the improvement of quality of life. Furthermore, the results revealed that there was a significant reduction in the women's measures abdominal circumference; that the pharmaceutical interventions directed to the patient influenced in the clinical results of fasting glucose, systolic and diastolic blood pressure; and that the changes observed in the clinical outcomes of diastolic blood pressure, triglycerides and abdominal circumference impacted on the quality of life related to the somatic manifestations.
eu_rights_str_mv openAccess
format masterThesis
id UFG-2_4e8d99ae5e727f48fa6eb02064e2c5db
identifier_str_mv AQUINO, Aline Teixeira de. Impacto da atenção farmacêutica na qualidade de vida e no perfil clínico de pacientes com hipertensão arterial assistidos pela estratégia saúde de família. 2013. 94 f. Dissertação (Mestrado Ciências da Saúde) - Universidade Federal de Goiás, Goiânia, 2013.
instacron_str UFG
institution UFG
instname_str Universidade Federal de Goiás (UFG)
language por
network_acronym_str UFG-2
network_name_str Repositório Institucional da UFG
oai_identifier_str oai:repositorio.bc.ufg.br:tede/9212
publishDate 2013
publishDateSort 2013
publisher.none.fl_str_mv Universidade Federal de Goiás
reponame_str Repositório Institucional da UFG
repository.mail.fl_str_mv grt.bc@ufg.br
repository.name.fl_str_mv Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)
repository_id_str oai:repositorio.bc.ufg.br:tede/1234
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/4.0/
spelling Amaral, Rita Goretihttp://lattes.cnpq.br/3665611660713029Lima, Dione Marçalhttp://lattes.cnpq.br/4310011929664114Amaral, Rita GoretiGarrote, Clévia Ferreira DuarteZampieri , Ana Lúcia Teixeira de Carvalhohttp://lattes.cnpq.br/7587958099382633Aquino, Aline Teixeira de2019-01-09T13:08:46Z2013-10-11AQUINO, Aline Teixeira de. Impacto da atenção farmacêutica na qualidade de vida e no perfil clínico de pacientes com hipertensão arterial assistidos pela estratégia saúde de família. 2013. 94 f. Dissertação (Mestrado Ciências da Saúde) - Universidade Federal de Goiás, Goiânia, 2013.http://repositorio.bc.ufg.br/tede/handle/tede/9212Introduction: Pharmaceutical care is a practice model that allows direct interaction between the pharmacist and the patient and the healthcare team. This practice uses the pharmacotherapeutic follow-up as a tool in the identification and resolution of Drug Related Problems, which can contribute to rational drug use and collaborate with achieving positive clinical outcomes that minimize the physical and psychosocial impact that chronic diseases and their treatment can promote the quality of life of patients. Objective: The aim of this study was to evaluate the impact of pharmaceutical care on quality of life and on clinical profile of patients with hypertension, assisted by the Family Health Strategy. Methods: Was conducted a longitudinal intervention study involving 29 patients with hypertension who were assisted by the Family Health Strategy of two Basic Health Units at the sanitary district north in the city of Goiânia - GO. They received pharmacotherapeutic follow-up for 12 months, through systematized, pre-schedule and documented home visits. Were included patients that had at least two of the following inclusion criteria: blood pressure greater than or equal to 140x90 mm ​​Hg, using three or more drugs, change in the therapeutic regimen two or more times in the last year , presence of co-morbidities, and history of non-adherence to antihypertensive therapy. Data collection was performed using follow-up pharmacotherapeutic reports, visits reports and form registration of clinical and laboratory parameters, “Mini Cuestionario de Calidad de Vida en Hipertensión Arterial” (Minichal) and Morisky-Green-Levine Questionnaire. The variables studied were the socio economic and demographic profile, clinical profile, lifestyle, Drug Related Problems, adherence to antihypertensive therapy and quality of life. For descriptive statistics were used mean, standard deviation and measures of absolute and relative frequency. For statistical tests were used the McNemar parametric test, odds ratio, and linear mixed models, generalized mixed models, linear mixed models. The threshold for statistical significance set at p <0.05, with a confidence interval of 95%.Results: The results showed that there was a reduction in the number of drug-related problem of security, increased self-reported adherence to antihypertensive treatment. There was improvement in quality of life related to the somatic manifestations domain and its correlation with the reduction in the number of drug-related problem of security. There was a significant reduction in abdominal circumference of female patients, there were found correlation between the quality of life for the somatic manifestations domain and the clinical outcomes of diastolic blood pressure, triglycerides and abdominal circumference. Just the diastolic blood pressure showed correlated with mental state domain of quality of life. There was a positive correlation between interventions directed to the patient related with the medications domain and the changes in the clinical results for fasting glucose. The life style domain presented correlation with systolic and diastolic blood pressure. Conclusions: The results showed that the pharmaceutical care reduced the number of security Drug Related Problems, improved quality of life related to the somatic manifestations domain. There was an increase in adherence to antihypertensive treatment declared by patients; however this did not influence the improvement of quality of life. Furthermore, the results revealed that there was a significant reduction in the women's measures abdominal circumference; that the pharmaceutical interventions directed to the patient influenced in the clinical results of fasting glucose, systolic and diastolic blood pressure; and that the changes observed in the clinical outcomes of diastolic blood pressure, triglycerides and abdominal circumference impacted on the quality of life related to the somatic manifestations.Introdução: A Atenção Farmacêutica (AF) é um modelo de prática que permite a interação direta do farmacêutico com o paciente e equipe de saúde. Esta prática utiliza o acompanhamento farmacoterapêutico como ferramenta na identificação e resolução de Problemas Relacionados a Medicamentos (PRM) que pode contribuir para uso racional de medicamentos. Além disso, pode colaborar com a obtenção de resultados clínicos positivos, que minimizam o impacto físico e psicossocial que as doenças crônicas e seu tratamento podem promover na qualidade de vida dos pacientes. Objetivo: O objetivo deste estudo foi avaliar o impacto da Atenção Farmacêutica na qualidade de vida e no perfil clínico de pacientes com hipertensão arterial, assistidos pela Estratégia Saúde da Família. Métodos: Foi conduzido um estudo longitudinal de intervenção, envolvendo 29 pacientes com hipertensão arterial. Estes receberam acompanhamento farmacoterapêutico por 12 meses, através de visitas domiciliares sistematizadas, pré-agendadas e documentadas. A coleta de dados foi realizada utilizando fichas de acompanhamento farmacoterapêutico e de registro de parâmetros clínicos e laboratoriais, relatórios de visitas, o Miniquestionário de qualidade de vida (Minichal) e o Questionário de Morisky-Green-Levine. As variáveis estudadas foram o perfil sócio econômico e demográfico, perfil clínico, estilo de vida, Problemas Relacionados a Medicamentos, adesão à terapia antihipertensiva e qualidade de vida. Resultados: Os resultados mostraram que houve redução do número de Problemas Relacionados a Medicamentos categorizados como segurança; aumento da adesão autorreferida ao tratamento anti-hipertensivo. Observou-se melhora na qualidade de vida relacionada ao domínio manifestações somáticas e sua correlação com a redução do número de Problemas Relacionados a Medicamentos categorizados como segurança. Observou-se redução significativa na medida da circunferência abdominal nos pacientes do sexo feminino; verificou-se correlação entre a qualidade de vida referente ao domínio manifestações somáticas e os resultados clínicos de pressão arterial diastólica, triglicérides e circunferência abdominal. Para o domínio estado mental apenas pressão arterial diastólica mostrou correlação com a qualidade de vida. Observou-se correlação positiva entre as intervenções direcionadas ao paciente relacionadas ao domínio medicamentos e a alteração nos resultados clínicos para glicemia e domínio estilo de vida apresentou correlação com a pressão arterial sistólica e pressão arterial diastólica. Conclusões: Os resultados permitiram concluir que a Atenção Farmacêutica reduziu o número de Problemas Relacionados a Medicamentos categorizados como segurança, com melhora da qualidade de vida relacionada ao domínio manifestações somáticas. Houve um aumento na adesão ao tratamento antihipertensivo declarada pelos pacientes, entretanto esta não influenciou significativamente na melhora da qualidade de vida. Além disso, revelaram que houve redução significativa de medidas de circunferência abdominal feminina; que as intervenções farmacêuticas direcionadas ao paciente influenciaram nos resultados clínicos de glicemia, pressão arterial diastólica e sistólica; e que as alterações observadas nos resultados clínicos de pressão arterial diastólica, triglicérides e circunferência abdominal impactaram na qualidade de vida referente às manifestações somáticas.Fundação de Amparo à Pesquisa do Estado de Goiás - FAPEGapplication/pdfporUniversidade Federal de GoiásPrograma de Pós-graduação em Ciências da Saúde (FM)UFGBrasilFaculdade de Medicina - FM (RG)http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessAtenção farmacêuticaHipertensão arterialAdesão à medicaçãoQualidade de vidaPharmaceutical careHypertensionMedication adherenceQuality of lifeMEDICINA::ANATOMIA PATOLOGICA E PATOLOGIA CLINICAImpacto da atenção farmacêutica na qualidade de vida e no perfil clínico de pacientes com hipertensão arterial assistidos pela estratégia saúde de famíliaImpact of pharmaceutical care on the quality of life and clinical profile of patients with arterial hypertension assisted by the family health strategyinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesis-100686431261774531060060060060015457724759504863387337577453819502453-961409807440757778reponame:Repositório Institucional da UFGinstname:Universidade Federal de Goiás (UFG)instacron:UFGORIGINALDissertação - Aline Teixeira de Aquino - 2013.pdfDissertação - Aline Teixeira de Aquino - 2013.pdfapplication/pdf4739061http://repositorio.bc.ufg.br/tede/bitstreams/3c41d5a9-18db-4f0e-a206-97eb972d61c1/download1b5845121203b85190fdc0482b0c2a3dMD55LICENSElicense.txtlicense.txttext/plain; charset=utf-82165http://repositorio.bc.ufg.br/tede/bitstreams/5d456919-a06e-4117-8468-1af213a0e161/downloadbd3efa91386c1718a7f26a329fdcb468MD51CC-LICENSElicense_urllicense_urltext/plain; charset=utf-849http://repositorio.bc.ufg.br/tede/bitstreams/10fb2aae-e6aa-436e-9373-4f87809c047c/download4afdbb8c545fd630ea7db775da747b2fMD52license_textlicense_texttext/html; charset=utf-80http://repositorio.bc.ufg.br/tede/bitstreams/bf4cca6b-1bc3-43de-89db-fc7c7b431bcf/downloadd41d8cd98f00b204e9800998ecf8427eMD53license_rdflicense_rdfapplication/rdf+xml; charset=utf-80http://repositorio.bc.ufg.br/tede/bitstreams/71f64e2b-b730-4576-9e46-ef3422651e5d/downloadd41d8cd98f00b204e9800998ecf8427eMD54tede/92122019-01-09 11:08:46.477http://creativecommons.org/licenses/by-nc-nd/4.0/Acesso Abertoopen.accessoai:repositorio.bc.ufg.br:tede/9212http://repositorio.bc.ufg.br/tedeRepositório InstitucionalPUBhttps://repositorio.bc.ufg.br/tedeserver/oai/requestgrt.bc@ufg.bropendoar:oai:repositorio.bc.ufg.br:tede/12342019-01-09T13:08:46Repositório Institucional da UFG - Universidade Federal de Goiás (UFG)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
spellingShingle Impacto da atenção farmacêutica na qualidade de vida e no perfil clínico de pacientes com hipertensão arterial assistidos pela estratégia saúde de família
Aquino, Aline Teixeira de
Atenção farmacêutica
Hipertensão arterial
Adesão à medicação
Qualidade de vida
Pharmaceutical care
Hypertension
Medication adherence
Quality of life
MEDICINA::ANATOMIA PATOLOGICA E PATOLOGIA CLINICA
status_str publishedVersion
title Impacto da atenção farmacêutica na qualidade de vida e no perfil clínico de pacientes com hipertensão arterial assistidos pela estratégia saúde de família
title_full Impacto da atenção farmacêutica na qualidade de vida e no perfil clínico de pacientes com hipertensão arterial assistidos pela estratégia saúde de família
title_fullStr Impacto da atenção farmacêutica na qualidade de vida e no perfil clínico de pacientes com hipertensão arterial assistidos pela estratégia saúde de família
title_full_unstemmed Impacto da atenção farmacêutica na qualidade de vida e no perfil clínico de pacientes com hipertensão arterial assistidos pela estratégia saúde de família
title_short Impacto da atenção farmacêutica na qualidade de vida e no perfil clínico de pacientes com hipertensão arterial assistidos pela estratégia saúde de família
title_sort Impacto da atenção farmacêutica na qualidade de vida e no perfil clínico de pacientes com hipertensão arterial assistidos pela estratégia saúde de família
topic Atenção farmacêutica
Hipertensão arterial
Adesão à medicação
Qualidade de vida
Pharmaceutical care
Hypertension
Medication adherence
Quality of life
MEDICINA::ANATOMIA PATOLOGICA E PATOLOGIA CLINICA
url http://repositorio.bc.ufg.br/tede/handle/tede/9212